LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

LLY

1,057.51

+1.46%↑

JNJ

208.35

-1.04%↓

ABBV

222.91

-0.6%↓

UNH

328.46

-0.81%↓

AZN

90.63

+0.8%↑

Search

Omnicell Inc

Fechado

SetorSaúde

46.1 0.7

Visão Geral

Variação de preço das ações

24h

Atual

Mín

45.03

Máximo

46.83

Indicadores-chave

By Trading Economics

Rendimento

-177K

5.5M

Vendas

20M

311M

P/E

Médio do Setor

100.628

76.798

EPS

0.51

Margem de lucro

1.758

Funcionários

3,600

EBITDA

524K

31M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+1.18% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

585M

2B

Abertura anterior

45.4

Fecho anterior

46.1

Sentimento de Notícias

By Acuity

50%

50%

167 / 374 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Strong Bearish Evidence

Omnicell Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de dez. de 2025, 23:54 UTC

Ações em Alta

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 de dez. de 2025, 23:51 UTC

Ganhos

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 de dez. de 2025, 23:39 UTC

Grandes Movimentos do Mercado

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 de dez. de 2025, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 de dez. de 2025, 21:40 UTC

Ganhos

Nike Sales Tick Up, But China Weakness Persists

18 de dez. de 2025, 23:45 UTC

Conversa de Mercado

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 de dez. de 2025, 23:37 UTC

Conversa de Mercado
Ganhos

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 de dez. de 2025, 23:36 UTC

Conversa de Mercado

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 de dez. de 2025, 23:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 de dez. de 2025, 23:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 de dez. de 2025, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 de dez. de 2025, 22:59 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 de dez. de 2025, 22:58 UTC

Aquisições, Fusões, Aquisições de Empresas

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 de dez. de 2025, 22:57 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 de dez. de 2025, 22:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 de dez. de 2025, 22:55 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:59 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

18 de dez. de 2025, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

18 de dez. de 2025, 21:35 UTC

Ganhos

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 de dez. de 2025, 21:31 UTC

Ganhos

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Greater China Rev Down 17% >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q EPS 53c >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Apparel Rev $3.91B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Equipment Rev $550M >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q N Amer Rev $5.63B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Footwear Rev $7.66B >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 de dez. de 2025, 21:15 UTC

Ganhos

Nike 2Q Greater China Rev $1.42B >NKE

Comparação entre Pares

Variação de preço

Omnicell Inc Previsão

Preço-alvo

By TipRanks

1.18% parte superior

Previsão para 12 meses

Média 46.33 USD  1.18%

Máximo 50 USD

Mínimo 43 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Omnicell Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

3

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

24.23 / 30.44Suporte e Resistência

Curto Prazo

Strong Bearish Evidence

Médio Prazo

Strong Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

167 / 374 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat